Management of Hepatocellular Carcinoma in Africa
Nov
18
2024
Convention Center: Room 23
3:45 PM - 4:45 PM
Description
Organized by the AASLD Global Outreach and Engagement Committee and the Society on Liver Diseases in Africa as a joint program, presenters in this session discuss the burden of HCC in Africa; current management guidelines for HCC in Africa; emerging basic science research on HCC in Africa; and current treatment approaches and ways of increasing access to systemic therapies for HCC in Africa.Journey Maps
Presentations
3:45 PM - 3:50 PM
Nov
18
2024
San Diego, CA
Introduction by Dr. Roberts and Dr. Spearman
Lewis R Roberts, MBChB, PhD, FAASLD, Moderator
DEI
Liver Cancer
3:50 PM - 3:55 PM
Nov
18
2024
San Diego, CA
Hepatocellular Carcinoma Clinical Case Presentation
Catherine W Spearman, PhD, Presenter
DEI
Liver Cancer
3:55 PM - 4:10 PM
Nov
18
2024
San Diego, CA
Overview of Hepatocellular Carcinoma Management Guidelines for Africa
Ashraf O Osman Prof, MD,FAASLD, Presenter
DEI
Liver Cancer
4:10 PM - 4:20 PM
Nov
18
2024
San Diego, CA
Hepatocellular Carcinoma Treatment Options and Outcomes in Sub-Saharan Africa
Catherine W Spearman, PhD, Presenter
DEI
Liver Cancer
4:20 PM - 4:30 PM
Nov
18
2024
San Diego, CA
Access to Systemic Therapies for Hepatocellular Carcinoma in Africa
Ghassan K. Abou-Alfa, Presenter
DEI
Liver Cancer
4:30 PM - 4:40 PM
Nov
18
2024
San Diego, CA
Hepatocellular Carcinoma Basic Science Research in Africa
Lewis R Roberts, MBChB, PhD, FAASLD, Presenter
DEI
Liver Cancer
4:40 PM - 4:45 PM
Nov
18
2024
San Diego, CA
Questions and Answers
Catherine W Spearman, PhD, Moderator
DEI
Liver Cancer
Objectives
- Review the burden of HCC in Africa, and risk factors and natural history.
- Describe the current treatment approach and outcomes for HCC in Africa.
- Discuss the limited access to systemic therapies for HCC in Africa and ways to mitigate access barriers.
Chair
Kidist K Yimam, MD
California Pacific Medical Center